DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis

Journal Article · · Toxicological Sciences
 [1];  [1];  [1];  [2];  [1];  [3];  [4];  [4];  [5];  [1];  [4];  [1]
  1. Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079
  2. Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079, State University of New York at Geneseo, Geneseo, New York 14454
  3. Core Metabolomics Laboratory, Arkansas Children’s Research Institute, Little Rock, Arkansas 72202
  4. Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23298
  5. Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas 77843

Abstract Nonalcoholic fatty liver disease (NAFLD) is becoming a major etiological risk factor for hepatocellular carcinoma (HCC) in the United States and other Western countries. In this study, we investigated the role of gene-specific promoter cytosine DNA methylation and gene expression alterations in the development of NAFLD-associated HCC in mice using (1) a diet-induced animal model of NAFLD, (2) a Stelic Animal Model of nonalcoholic steatohepatitis-derived HCC, and (3) a choline- and folate-deficient (CFD) diet (CFD model). We found that the development of NAFLD and its progression to HCC was characterized by down-regulation of glycine N-methyltransferase (Gnmt) and this was mediated by progressive Gnmt promoter cytosine DNA hypermethylation. Using a panel of genetically diverse inbred mice, we observed that Gnmt down-regulation was an early event in the pathogenesis of NAFLD and correlated with the extent of the NAFLD-like liver injury. Reduced GNMT expression was also found in human HCC tissue and liver cancer cell lines. In in vitro experiments, we demonstrated that one of the consequences of GNMT inhibition was an increase in genome methylation facilitated by an elevated level of S-adenosyl-L-methionine. Overall, our findings suggest that reduced Gnmt expression caused by promoter hypermethylation is one of the key molecular events in the development of NAFLD-derived HCC and that assessing Gnmt methylation level may be useful for disease stratification.

Sponsoring Organization:
USDOE
OSTI ID:
1565976
Journal Information:
Toxicological Sciences, Journal Name: Toxicological Sciences Journal Issue: 2 Vol. 170; ISSN 1096-6080
Publisher:
Oxford University PressCopyright Statement
Country of Publication:
United States
Language:
English

References (43)

Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma journal March 1998
Comparison of hepatocellular carcinoma in Eastern versus Western populations: Hepatocellular Carcinoma: East vs West journal September 2016
Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015: Long-Term Survival in Patients With HCC journal April 2018
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice journal December 2007
A novel role of the tumor suppressor GNMT in cellular defense against DNA damage: GNMT prevents DNA damage journal October 2013
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma journal March 2013
Furan-induced transcriptomic and gene-specific DNA methylation changes in the livers of Fischer 344 rats in a 2-year carcinogenicity study journal July 2016
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma journal February 2013
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma journal December 2000
A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulometric electrochemical detection journal August 1999
Animal models of NAFLD from a hepatologist's point of view journal May 2019
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma journal January 2014
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma journal June 2017
Characterization of the 5′ regulatory region of the human Glycine N-methyltransferase gene journal August 2009
Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis journal June 2018
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer journal September 2016
Global trends and predictions in hepatocellular carcinoma mortality journal August 2017
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma journal January 2018
Should we undertake surveillance for HCC in patients with NAFLD? journal February 2018
Preclinical models of non-alcoholic fatty liver disease journal February 2018
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer journal August 2018
Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet journal July 2012
The multi-functional roles of GNMT in toxicology and cancer journal January 2013
Glycine N-methyltransferase deficiency: A new patient with a novel mutation journal January 2003
Subspecific origin and haplotype diversity in the laboratory mouse journal May 2011
Analyzing real-time PCR data by the comparative CT method journal June 2008
Hepatocellular carcinoma journal April 2016
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis journal September 2018
The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease journal December 2017
MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma journal August 2018
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma journal October 2015
Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. journal January 1994
Glycine N -methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates journal June 2018
DNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma journal May 2002
Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury journal June 2013
Molecular genomic landscapes of hepatobiliary cancer journal April 2018
Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation journal May 2017
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 journal March 2009
A Novel Tumor Suppressor Function of Glycine N-Methyltransferase Is Independent of Its Catalytic Activity but Requires Nuclear Localization journal July 2013
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease journal May 2015
Glycine N-Methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis journal December 2011
Cancers with increasing incidence trends in the United States: 1999 through 2008 journal January 2012
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure journal April 2018